Advantage over the cellular damage prevention effect of the erythropoietin-derived peptide

摘要

Since the peptide according to the present invention has a simpler structure than the conventional natural human erythropoietin, it is easy to pass through the tissue-blood barrier, has excellent physiological activity in terms of cell protective activity, and has a low production cost. For example, the pharmaceutical composition containing the erythropoietin-derived peptide of the present invention as an active ingredient has economic advantages and no side effects on cell proliferation. It can be usefully used as a pharmaceutical composition for prevention or treatment, and prevention of cell damage.